Glucose and haemoglobin in the assessment of prognosis after first hospitalisation for heart failure
- 15 May 2006
- Vol. 92 (10) , 1441-1446
- https://doi.org/10.1136/hrt.2005.080895
Abstract
Objective: To examine the relationship with outcome of plasma haemoglobin and glucose concentrations, measured soon after first hospital admission with chronic heart failure (CHF), in standard clinical practice. Methods and results: Hospital records of 528 patients (43% women, mean age 70 years) with first hospital admission for CHF were reviewed. During follow up (mean 1257 days, range 520–1800), 240 (45%) patients died. On admission, 140 of 528 (27%) and at discharge 179 of 472 survivors (38%) were receiving treatment for diabetes. World Health Organization criteria for anaemia were met by 39% of men and 43% of women. Lower haemoglobin (hazard ratio 0.879, 95% confidence interval (CI) 0.828 to 0.933, p < 0.0001) and higher plasma glucose (hazard ratio 1.034, 95% CI 1.008 to 1.061, p = 0.009) had univariate association with all-cause mortality. On multivariate analysis, compared with patients with a normal haemoglobin for their sex, hazard ratio was 1.415 (95% CI 1.087 to 1.841, p = 0.010) for those with low haemoglobin. All-cause mortality fell linearly for haemoglobin up to 159 g/l, above which mortality increased. Glucose above the highest quartile (> 10 mmol/l) was an independent predictor of mortality (hazard ratio 1.966, 95% CI 1.376 to 2.810, p = 0.0002). In survivors of the index admission the association between glucose and mortality was linear, the relationship being stronger for patients without diabetes. Conclusions: Lower haemoglobin and higher plasma glucose are associated with all-cause mortality in CHF. Higher glucose is associated with mortality irrespective of diabetic status.Keywords
This publication has 30 references indexed in Scilit:
- Anemia and Its Relationship to Clinical Outcome in Heart FailureCirculation, 2004
- Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trialEuropean Heart Journal, 2004
- Clinical Determinants of Mortality in Patients With Angiographically Diagnosed Ischemic or Nonischemic CardiomyopathyJournal of the American College of Cardiology, 1997
- Development and Prospective Validation of a Clinical Index to Predict Survival in Ambulatory Patients Referred for Cardiac Transplant EvaluationCirculation, 1997
- The epidemiology of heart failureEuropean Heart Journal, 1997
- Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 yearJournal of the American College of Cardiology, 1995
- Prediction of mortality in mild to moderately symptomatic patients with left ventricular dysfunction. The role of the New York Heart Association classification, cardiopulmonary exercise testing, two-dimensional echocardiography and Holter monitoring.1994
- Predictors of prognosis in severe chronic heart failureAmerican Heart Journal, 1992
- Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients.Circulation, 1991
- Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure.Circulation, 1986